New England Research & Management, Inc. - Q2 2020 holdings

$140 Million is the total value of New England Research & Management, Inc.'s 141 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 83.9% .

 Value Shares↓ Weighting
CHD BuyChurch and Dwightcs$5,761,000
+21.3%
74,525
+0.7%
4.12%
+1.7%
PFE BuyPfizercs$2,718,000
+28.5%
83,109
+28.2%
1.94%
+7.7%
MRK BuyMerckcs$2,712,000
+34.5%
35,070
+33.8%
1.94%
+12.7%
UPS BuyUPScs$2,688,000
+22.6%
24,175
+3.0%
1.92%
+2.8%
BMY BuyBristol Myers Squibbcs$2,301,000
+16.8%
39,137
+10.8%
1.65%
-2.1%
LDOS NewLeidos Holdings, Inc.cs$2,106,00022,479
+100.0%
1.51%
VZ BuyVerizon Comm.cs$2,043,000
+56.1%
37,060
+52.1%
1.46%
+30.8%
HON BuyHoneywell Int'l.cs$1,762,000
+76.6%
12,187
+63.3%
1.26%
+48.0%
ABBV BuyAbbVie Inc.cs$1,444,000
+90.5%
14,705
+47.7%
1.03%
+59.7%
FB BuyFacebook Inccs$1,438,000
+36.8%
6,331
+0.5%
1.03%
+14.7%
WM BuyWaste Management Inc.cs$1,359,000
+326.0%
12,830
+271.9%
0.97%
+257.4%
CTXS NewCitrix Systemscs$1,342,0009,075
+100.0%
0.96%
AMD NewAdvanced Micro Devicescs$1,214,00023,075
+100.0%
0.87%
QSR BuyRestaurant Brands Int'lcs$1,202,000
+45.2%
22,007
+6.4%
0.86%
+21.6%
KNX BuyKnight Swift Transportationcs$1,152,000
+121.5%
27,625
+74.3%
0.82%
+85.6%
NVS BuyNovartis AG ADScs$1,107,000
+15.6%
12,670
+9.0%
0.79%
-3.2%
BSX BuyBoston Scientificcs$1,078,000
+80.0%
30,700
+67.3%
0.77%
+50.9%
ATVI NewActivision Blizzardcs$1,042,00013,730
+100.0%
0.75%
SBUX BuyStarbuckscs$1,023,000
+55.7%
13,895
+39.0%
0.73%
+30.5%
V BuyVisacs$983,000
+51.2%
5,087
+26.0%
0.70%
+26.7%
AMN BuyAMN Healthcare Servicescs$935,000
+107.3%
20,660
+164.7%
0.67%
+73.8%
BDX BuyBecton Dickinsoncs$921,000
+113.7%
3,850
+105.3%
0.66%
+79.1%
J BuyJacobs Engineeringcs$916,000
+114.0%
10,800
+100.0%
0.66%
+79.5%
CRUS NewCirrus Logiccs$888,00014,375
+100.0%
0.64%
AMGN BuyAmgencs$880,000
+193.3%
3,729
+152.1%
0.63%
+146.1%
LITE BuyLumentum Holdingscs$859,000
+145.4%
10,550
+122.1%
0.62%
+105.7%
EA BuyElectronic Artscs$787,000
+63.6%
5,960
+24.2%
0.56%
+37.0%
JNPR BuyJunipercs$758,000
+90.9%
33,150
+59.8%
0.54%
+59.9%
SYY BuySysco Corpcs$719,000
+35.9%
13,154
+13.4%
0.52%
+13.9%
LEN NewLennarcs$636,00010,325
+100.0%
0.46%
COST BuyCostco Wholesalecs$622,000
+123.7%
2,050
+110.3%
0.44%
+87.8%
ALNY NewAlnylam Pharmaceuticals, Inc.cs$607,0004,100
+100.0%
0.43%
CRM BuySalesforce.comcs$572,000
+36.8%
3,055
+5.2%
0.41%
+14.6%
ECL BuyEcolabcs$572,000
+74.9%
2,875
+36.9%
0.41%
+46.6%
PPC NewPilgrim's Pride Corporationcs$513,00030,350
+100.0%
0.37%
PFPT NewProofpoint, Inc.cs$511,0004,600
+100.0%
0.37%
QRVO NewQorvo Inccs$497,0004,500
+100.0%
0.36%
VRSK NewVerisk Analyticscs$477,0002,800
+100.0%
0.34%
SONY NewSony Corpcs$465,0006,720
+100.0%
0.33%
FLIR NewFLIR Systems Inc.cs$449,00011,058
+100.0%
0.32%
GILD BuyGilead Sciencescs$416,000
+76.3%
5,410
+71.2%
0.30%
+47.5%
AVGO BuyBroadcomcs$395,000
+38.6%
1,250
+4.2%
0.28%
+16.5%
NFLX BuyNetflixcs$382,000
+72.1%
840
+42.4%
0.27%
+43.7%
JPM NewJ.P. Morgan Chasecs$378,0004,023
+100.0%
0.27%
BIIB NewBiogen Ideccs$368,0001,375
+100.0%
0.26%
OSK NewOshkosh Corpcs$362,0005,050
+100.0%
0.26%
EBS NewEmergent Biosolutionscs$356,0004,500
+100.0%
0.26%
AMWD NewAmerican Woodmark Corporationcs$348,0004,595
+100.0%
0.25%
DHI NewDR Hortoncs$345,0006,225
+100.0%
0.25%
TWTR NewTwittercs$267,0008,950
+100.0%
0.19%
IRDM NewIridium Communicationscs$267,00010,502
+100.0%
0.19%
EW BuyEdwards Lifesciencescs$261,000
+9.7%
3,780
+200.0%
0.19%
-7.9%
SHW NewSherwin-Williamscs$246,000425
+100.0%
0.18%
WLK NewWestlake Chemicalcs$233,0004,350
+100.0%
0.17%
PPG NewPPG Industriescs$222,0002,090
+100.0%
0.16%
VIAV NewViavi Solutionscs$182,00014,250
+100.0%
0.13%
UNVR NewUnivar Solutions Inc.cs$181,00010,750
+100.0%
0.13%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-07-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Church and Dwight40Q3 20235.1%
Johnson & Johnson40Q3 20233.9%
Cisco Systems40Q3 20233.4%
Kimberly-Clark40Q3 20232.9%
Apple Computer40Q3 20233.4%
Exxon Mobil40Q3 20232.9%
Pfizer40Q3 20232.3%
Microsoft40Q3 20232.8%
CSX Corp40Q3 20232.2%
Merck40Q3 20231.9%

View New England Research & Management, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-16
13F-HR2024-02-06
13F-HR2023-10-10
13F-HR2023-07-05
13F-HR2023-04-06
13F-HR2023-01-09
13F-HR2022-10-06
13F-HR2022-07-20
13F-HR2022-04-20
13F-HR2022-01-05

View New England Research & Management, Inc.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (139737000.0 != 139743000.0)

Export New England Research & Management, Inc.'s holdings